Literature DB >> 2358629

Renal biopsy in patients 65 years of age or older. An analysis of the results of 334 biopsies.

R A Preston1, C L Stemmer, B J Materson, E Perez-Stable, V Pardo.   

Abstract

We studied the clinical and pathological data for 334 patients age 65 or more who underwent renal biopsy for acute renal failure (ARF, n = 55), subacute renal failure (SRF, n = 72), chronic renal failure (CRF, n = 57), proteinuria (n = 137), and hematuria (n = 13). Tissue diagnoses were glomerulopathy (n = 252, 75.4%), acute tubular lesions (n = 18), interstitial nephritis (n = 23), vascular diseases (n = 36, including 14 with cholesterol emboli), and five miscellaneous diagnoses. Of the 55 patients with ARF, 23 had a glomerular lesion, 15 had acute tubular necrosis, and 8 had acute interstitial nephritis. Of 72 patients with SRF, 49 had a glomerulopathy, 12 had a vascular disorder, and six had acute interstitial nephritis. Hence, patients with ARF or SRF exhibited a high potential for reversible lesions. Only 11.3% of patients with CRF had potentially reversible causes. The most common causes of proteinuria were membranous glomerulopathy (34.3%), minimal change disease (14.6%), focal segmental sclerosis (11.7%), and amyloidosis (8.8%). Of the 25 patients with advanced nephrosclerosis, 24 had renal failure, 20 were hypertensive, and 13 had cholesterol emboli. Of 33 patients with diabetes mellitus, 66.7% were found to have lesions not related to diabetes. We conclude that renal biopsy is most useful in older patients with ARF or SRF because of potentially reversible renal disease. Old age alone is not a contraindication to performing a renal biopsy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2358629     DOI: 10.1111/j.1532-5415.1990.tb01427.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  9 in total

Review 1.  The aging kidney: a review--part II.

Authors:  Fred G Silva
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

2.  How common is cholesterol embolism?

Authors:  S S Cross
Journal:  J Clin Pathol       Date:  1991-10       Impact factor: 3.411

3.  Cholesterol emboli syndrome--uncommon or unrecognized?

Authors:  S P Bell; A Frankel; E A Brown
Journal:  J R Soc Med       Date:  1997-10       Impact factor: 5.344

4.  Atheroembolism.

Authors:  John S. Smyth; John E. Scoble
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-06

5.  Renal biopsy in very elderly patients (over 80 years): clinical presentation, histological diagnosis, and long-term outcome.

Authors:  Martin Planchais; Benoit Brilland; Julien Demiselle; Virginie Besson; Agnès Duveau; Anne Croué; Maud Cousin; Jean-François Subra; Jean-François Augusto; Anne-Sophie Garnier
Journal:  Int Urol Nephrol       Date:  2020-02-29       Impact factor: 2.370

Review 6.  Use of renal biopsy in the elderly.

Authors:  Nasreen Mohamed; Rohan John
Journal:  Int Urol Nephrol       Date:  2010-11-28       Impact factor: 2.370

7.  Renal biopsy in the very elderly.

Authors:  Dimitrios-Anestis Moutzouris; Leal Herlitz; Gerald B Appel; Glen S Markowitz; Bernard Freudenthal; Jai Radhakrishnan; Vivette D D'Agati
Journal:  Clin J Am Soc Nephrol       Date:  2009-05-14       Impact factor: 8.237

8.  Favorable outcome in atheroembolic renal disease with pulse steroid therapy.

Authors:  A Sharma; R Hada; R K Agrawal; A Baral
Journal:  Indian J Nephrol       Date:  2012-11

9.  Burden of kidney failure from atheroembolic disease and association with survival in people receiving dialysis in Australia and New Zealand: a multi-centre registry study.

Authors:  Tahira Scott; Isabelle Ethier; Carmel Hawley; Elaine M Pascoe; Andrea K Viecelli; Arnold Ng; Yeoungjee Cho; David W Johnson
Journal:  BMC Nephrol       Date:  2021-12-02       Impact factor: 2.388

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.